Tags: AS | Japan | Astellas | OSI

Japan's Astellas to Buy US Drug Firm OSI for $4 Billion

Monday, 17 May 2010 09:16 AM

Astellas Pharma Inc., Japan's No. 2 drug maker, said Monday it will buy U.S. cancer drug company OSI Pharmaceuticals Inc. for $4 billion in cash in a bid to expand its cancer drug business worldwide.

Astellas said it will pay $57.50 per OSI share, up from $52 the Japanese company had offered earlier. The transaction will be completed within a month.

The acquisition is part of Astellas' drive to expand its cancer drug business worldwide. OSI's drugs include Tarceva, for lung cancer, which generated $1.2 billion in global sales last year.

The Japanese maker said it hopes to jointly develop cancer drugs with OSI.

Apart from cancer, OSI focuses on oncology, diabetes and obesity treatments.

© Copyright 2017 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

   
1Like our page
2Share
Companies
Astellas Pharma Inc., Japan's No. 2 drug maker, said Monday it will buy U.S. cancer drug company OSI Pharmaceuticals Inc. for $4 billion in cash in a bid to expand its cancer drug business worldwide.Astellas said it will pay $57.50 per OSI share, up from $52 the Japanese...
AS,Japan,Astellas,OSI
115
2010-16-17
Monday, 17 May 2010 09:16 AM
Newsmax Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved